Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

Targeted Therapy in NSCLC Part V: KRAS, MEK, BRAF and MET

03.06.2014 / Thomson Reuters Blog

In the fifth in this series on targeted therapy in non small cell lung cancer (NSCLC), a number of new pathways and potential targets for the future are reviewed. In particular, the mitogen-activated protein kinase (MAPK) pathway, which is preferentially activated in NSCLC. See Part I of the series here. Dependency of BRAF-mutant lung tumours […]

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: